Archive Newsletter
-
03.04.24 -- Explore Options For A More Productive Cell Banking Process
3/4/2024
03/04/24 Cell & Gene Newsletter
-
03.04.24 -- Managing Risks In Aseptic Processing Of CGT
3/4/2024
03/04/24 Cell & Gene Newsletter
-
03.01.24 -- Overcoming Hurdles On The Path To CGT Manufacturing
3/1/2024
03/01/24 Cell & Gene Newsletter
-
02.29.24 -- Maximize Adherent Cell Yields With Perfusion
2/29/2024
02/29/24 Cell & Gene Newsletter
-
02.29.24 -- FDA's CBER Issues Final Guidance For CAR T Cell Products
2/29/2024
02/29/24 Cell & Gene Newsletter
-
02.28.24 -- GMP Essentials: Optimizing Your Biotherapeutic Development
2/28/2024
02/28/24 Cell & Gene Newsletter
-
02.28.24 -- Inside Yescarta's Reduced Median Turnaround Time
2/28/2024
02/28/24 Cell & Gene Newsletter
-
02.27.24 -- Accelerate Your Cell And Gene Therapy Research
2/27/2024
02/27/24 Cell & Gene Newsletter
-
02.27.24 -- Shaping A Digitally Enabled Commercialization Road Map
2/27/2024
02/27/24 Cell & Gene Newsletter
-
02.26.24 -- Paving The Way For India's First Domestic CAR-T Approval
2/26/2024
02/26/24 Cell & Gene Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more